DAVITA INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
DAVITA INC. (DVA) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $291.85 million as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-02-11
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $291.85M.
- 2024-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $309.36M.
- 2023-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $322.84M.
- 2022-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $319.55M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2025-12-31 | $291.85M 10-K · filed 2026-02-11 |
| 2024-12-31 | $309.36M 10-K · filed 2026-02-11 |
| 2023-12-31 | $322.84M 10-K · filed 2025-02-13 |
| 2022-12-31 | $319.55M 10-K · filed 2024-02-14 |
| 2021-12-31 | $322.06M 10-K · filed 2023-02-22 |
| 2020-12-31 | $275.39M 10-K · filed 2021-02-12 |
| 2020-03-31 | $257.75M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $247.25M 10-K · filed 2021-02-12 |
| 2019-09-30 | $254.97M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $246.26M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $233.21M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $367.16M 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |